Cascieri MA - Search Results

1

Structure-activity relationships of aminoalkyl and -aryl glycosides having insulin-like activity.

Durette PL, Bugianesi RL, Ponpipom MM, Shen TY, Cascieri MA, Glitzer MS, Katzen HM. Durette PL, et al. Among authors: cascieri ma. J Med Chem. 1978 Sep;21(9):854-9. doi: 10.1021/jm00207a003. J Med Chem. 1978. PMID: 722752

2

The role of H2O2 formation in the insulin-like and insulin antagonistic effects on fat cells of omega-aminoalkyl glycosides.

Cascieri MA, Mumford RA, Katzen HM. Cascieri MA, et al. Arch Biochem Biophys. 1979 Jun;195(1):30-44. doi: 10.1016/0003-9861(79)90324-2. Arch Biochem Biophys. 1979. PMID: 475387 No abstract available.

3

Azasteroids: structure-activity relationships for inhibition of 5 alpha-reductase and of androgen receptor binding.

Rasmusson GH, Reynolds GF, Steinberg NG, Walton E, Patel GF, Liang T, Cascieri MA, Cheung AH, Brooks JR, Berman C. Rasmusson GH, et al. Among authors: cascieri ma. J Med Chem. 1986 Nov;29(11):2298-315. doi: 10.1021/jm00161a028. J Med Chem. 1986. PMID: 3783591

4

4,4-Disubstituted piperidine high-affinity NK1 antagonists: structure-activity relationships and in vivo activity.

Stevenson GI, Huscroft I, MacLeod AM, Swain CJ, Cascieri MA, Chicchi GG, Graham MI, Harrison T, Kelleher FJ, Kurtz M, Ladduwahetty T, Merchant KJ, Metzger JM, MacIntyre DE, Sadowski S, Sohal B, Owens AP. Stevenson GI, et al. Among authors: cascieri ma. J Med Chem. 1998 Nov 5;41(23):4623-35. doi: 10.1021/jm980376b. J Med Chem. 1998. PMID: 9804702

5

Potent, selective 3-pyridylethanolamine beta3 adrenergic receptor agonists possessing a thiazole benzenesulfonamide pharmacophore.

Mathvink RJ, Tolman JS, Chitty D, Candelore MR, Cascieri MA, Colwell LF Jr, Deng L, Feeney WP, Forrest MJ, Hom GJ, MacIntyre DE, Tota L, Wyvratt MJ, Fisher MH, Weber AE. Mathvink RJ, et al. Among authors: cascieri ma. Bioorg Med Chem Lett. 2000 Sep 4;10(17):1971-3. doi: 10.1016/s0960-894x(00)00390-5. Bioorg Med Chem Lett. 2000. PMID: 10987429

6

Synthesis and biological evaluation of NK1 antagonists derived from L-tryptophan.

MacLeod AM, Cascieri MA, Merchant KJ, Sadowski S, Hardwicke S, Lewis RT, MacIntyre DE, Metzger JM, Fong TM, Shepheard S, et al. MacLeod AM, et al. Among authors: cascieri ma. J Med Chem. 1995 Mar 17;38(6):934-41. doi: 10.1021/jm00006a012. J Med Chem. 1995. PMID: 7535362

7

Discovery of 3-piperidinyl-1-cyclopentanecarboxamide as a novel scaffold for highly potent CC chemokine receptor 2 antagonists.

Yang L, Butora G, Jiao RX, Pasternak A, Zhou C, Parsons WH, Mills SG, Vicario PP, Ayala JM, Cascieri MA, MacCoss M. Yang L, et al. Among authors: cascieri ma. J Med Chem. 2007 May 31;50(11):2609-11. doi: 10.1021/jm070166b. Epub 2007 Apr 27. J Med Chem. 2007. PMID: 17461566

8

Tryptophan-derived NK1 antagonists: conformationally constrained heterocyclic bioisosteres of the ester linkage.

Lewis RT, Macleod AM, Merchant KJ, Kelleher F, Sanderson I, Herbert RH, Cascieri MA, Sadowski S, Ball RG, Hoogsteen K. Lewis RT, et al. Among authors: cascieri ma. J Med Chem. 1995 Mar 17;38(6):923-33. doi: 10.1021/jm00006a011. J Med Chem. 1995. PMID: 7699709

9

N-acyl-L-tryptophan benzyl esters: potent substance P receptor antagonists.

MacLeod AM, Merchant KJ, Cascieri MA, Sadowski S, Ber E, Swain CJ, Baker R. MacLeod AM, et al. Among authors: cascieri ma. J Med Chem. 1993 Jul 9;36(14):2044-5. doi: 10.1021/jm00066a015. J Med Chem. 1993. PMID: 8393115 No abstract available.

10

L-tryptophan urea amides as NK1/NK2 dual antagonists.

Qi H, Shah SK, Cascieri MA, Sadowski SJ, MaCcoss M. Qi H, et al. Among authors: cascieri ma. Bioorg Med Chem Lett. 1998 Aug 18;8(16):2259-62. doi: 10.1016/s0960-894x(98)00395-3. Bioorg Med Chem Lett. 1998. PMID: 9873524

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

134 results

Search Page